Thulium Laser Versus Holmium Laser Transurethral Enucleation of the Prostate: 18-Month Follow-up Data of a Single Center

Zhang, Fengbo; Shao, Qiang; Herrmann, Thomas; Tian, Ye; Zhang, Yuhai

doi:10.1016/j.urology.2011.12.018

Cited by 134 publications

(110 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It would have been of interest to assess if the regrowth rate of residual/recurrent adenomas after secondary treatment is higher compared to the patients with initial HoLEP and ThuLEP treatment. However, the reduction rates of the gland size and PSA levels after laser enucleation have been already reported sufficiently in previous studies [23][24][25]. Until now, the re-oper-Urol Int 2018;101:212-218 DOI: 10.1159/000489858 ation rate of primary or secondary laser enucleation is zero.…”

Section: Discussionmentioning

confidence: 83%

A Feasibility Study Utilizing the Thulium and Holmium Laser in Patients for the Treatment of Recurrent Benign Prostatic Hyperplasia after Previous Prostatic Surgery

Becker¹,

Netsch²,

Glybochko³

et al. 2018

Urol Int

View full text Add to dashboard Cite

Background: Transurethral resection of the prostate (TURP) is considered to be the standard treatment for patients with benign prostatic obstruction (BPO) ≤80 mL. However, up to 14.7% of the patients require secondary TURP due to recurrent BPO. The aim of our study was to describe specific features of holmium laser enucleation of the prostate (HoLEP) and thulium laser enucleation of the prostate (ThuLEP) in patients with recurrent BPO after previous prostate surgery. Materials and Methods: A total of 768 consecutive patients from our prospective collected database were retrospectively reviewed and divided into 4 groups: group A (489 patients) and group C (253 patients) underwent primary HoLEP and ThuLEP treatment, while group B (17 patients) and D (9 patients) included patients with recurrent BPO who were treated with HoLEP and ThuLEP, respectively. Results: There were no significant differences in preoperative parameters between the groups at primary (A and C) and secondary (B and D) treatment except their age. At 6-month follow-up, voiding parameters and symptom scores showed statistically significant improvements compared to baseline without differences between the groups. The mean operative time was comparable between the groups and did not differ significantly (p > 0.05). Conclusions: Laser enucleation for the treatment of recurrent BPO is feasible and seems to be a safe and effective procedure.

show abstract

Section: Discussionmentioning

confidence: 83%

A Feasibility Study Utilizing the Thulium and Holmium Laser in Patients for the Treatment of Recurrent Benign Prostatic Hyperplasia after Previous Prostatic Surgery

Becker¹,

Netsch²,

Glybochko³

et al. 2018

Urol Int

View full text Add to dashboard Cite

show abstract

“…The median number of procedures done per blade was 22 (range: 20-25) and 18 (17)(18)(19)(20) with the Piranha and VersaCut morcellators, respectively (p = 0.01). The median number of grams of prostate tissue retrieved per blade was 1499 (range: 1388-1539) and 943 (833-1248) with the Piranha and VersaCut morcellators, respectively (p = 0.04).…”

Section: Resultsmentioning

confidence: 99%

Towards optimizing prostate tissue retrieval following holmium laser enucleation of the prostate (HoLEP): Assessment of two morcellators and review of literature

Elshal

Mekkawy

Laymon

et al. 2015

CUAJ

View full text Add to dashboard Cite

Introduction: We assess different approaches to retrieve the enucleated adenoma after transurethral enucleation of the prostate, particularly using the holmium laser. Methods: A retrospective review through our prospectively maintained database was performed looking for safety and efficacy of two morcellators. The enucleation phase of the holmium laser enucleation of the prostate (HoLEP) was classically performed followed by retrieval of the intravesical adenoma using either the Piranha (Wolf Inc., Knittlingen, Germany) or VersaCut (Lumenis) morcellator. A PubMed-MEDLINE search was conducted for all transurethral enucleation procedures and relevant data regarding methods of prostate tissue retrieval were extracted. Results: Strictly limiting the study to 3 reusable blades with each morcellator, we performed 67 and 55 consecutive procedures with Piranha and VersaCut, respectively. There was no significant difference between the two morcellators regarding perioperative complications, apart from 5 bladder mucosal injuries with the VersaCut (9%). Furthermore, there were similar retrieved tissue weight, mechanical problems-rate, catheter-time and hospital-stay in both morcellators. However, the Piranha morcellator needed significantly less morcellation-time, needed to use cold loop to remove non-morcellated pieces and to score the adenoma by laser for better bite of the adenoma, and had a higher median morcellation-rate 6.2 (rate: 2.8-12) g/min. Despite little reporting on morcellation, we had data on the tissue retrieval rate (2.6 to 6.5 g/min with Piranha and 1.9 to 11 g/min with VersaCut. Furthermore, bladder mucosal injury was reported in 1.4% and 0.7 to 5.7% with Piranha and VersaCut, respectively; bladder perforation with VersaCut was experienced in about 0.1 to 1.5% of patients. Our study is limited by its non-randomization. Conclusion: The Piranha morcellator was the most efficient and safe way to retrieve tissue after a transurethral enucleation of a prostate adenoma.

show abstract

“…As a result, only five studies provided surgical data for analysis. The latter studies include two prospective cohorts (level of evidence IIa) and three randomized controlled trials comparing ThuLEP with TURP or HoLEP (level of evidence 1b) [6][7][8][9][10]. The study of Shao et al [8] was in Chinese, and data were extracted by the English abstract and after personal communication with the authors.…”

Section: Resultsmentioning

confidence: 99%

“…The study of Shao et al [8] was in Chinese, and data were extracted by the English abstract and after personal communication with the authors. Still, given that an updated review of the same patient cohort was available by the same group of authors, the particular publication was not reviewed in the current analysis [8,9].…”

Section: Resultsmentioning

confidence: 99%

Transurethral anatomical enucleation of the prostate with Tm:YAG support (ThuLEP): review of the literature on a novel surgical approach in the management of benign prostatic enlargement

Kyriazis

Świniarski²,

Jutzi

et al. 2015

World J Urol

View full text Add to dashboard Cite

show abstract

Thulium Laser Versus Holmium Laser Transurethral Enucleation of the Prostate: 18-Month Follow-up Data of a Single Center

Cited by 134 publications

References 26 publications

A Feasibility Study Utilizing the Thulium and Holmium Laser in Patients for the Treatment of Recurrent Benign Prostatic Hyperplasia after Previous Prostatic Surgery

A Feasibility Study Utilizing the Thulium and Holmium Laser in Patients for the Treatment of Recurrent Benign Prostatic Hyperplasia after Previous Prostatic Surgery

Towards optimizing prostate tissue retrieval following holmium laser enucleation of the prostate (HoLEP): Assessment of two morcellators and review of literature

Transurethral anatomical enucleation of the prostate with Tm:YAG support (ThuLEP): review of the literature on a novel surgical approach in the management of benign prostatic enlargement

Contact Info

Product

Resources

About